Is group A thawed plasma suitable as the first option for emergency release transfusion?
We propose that group A plasma may be an acceptable alternative to AB plasma as the first option in the emergency release setting.
UDCA therapy in PSC patients was associated with a decrease in cholestasis, but no consistent improvement in hepatic inflammation, fibrosis or histological stage of the disease. Immunomodulatory effects of UDCA in PSC do not appear to be HLA-restricted.